Join STAT Brand Studio and Real Chemistry on Wednesday, April 3, at 1 p.m. ET as we explore the pertinent questions facing the industry and uncover the opportunities and challenges of GLP-1 drugs.
In a rapidly evolving landscape where obesity drugs have captured widespread attention, it's crucial to discern the signal from the noise.
This virtual event aims to provide a grounded perspective on today's realities. Industry experts will dive into the trends shaping the market for GLP-1s and offer invaluable insights for biopharma executives.
No comments